Lexicon Pharmaceuticals LXRX Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's software and technology licenses, net?
- Lexicon Pharmaceuticals (LXRX) reported software and technology licenses, net of $368K in Q1 2026.
- How has Lexicon Pharmaceuticals's software and technology licenses, net changed year-over-year?
- Lexicon Pharmaceuticals's software and technology licenses, net decreased by 0.0% year-over-year, from $368K to $368K.
- What is the long-term trend for Lexicon Pharmaceuticals's software and technology licenses, net?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's software and technology licenses, net has grown at a -21.5% compound annual growth rate (CAGR), from $1.23M to $368K.